Terms: = Breast cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Clinical Outcome
240 results:
1. Treatment Monitoring of a Patient with Synchronous Metastatic Angiosarcoma and breast cancer Using ctDNA.
Vannas C; Escobar M; Österlund T; Andersson D; Mouhanna P; Soomägi A; Molin C; Wennergren D; Fagman H; Ståhlberg A
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612833
[TBL] [Abstract] [Full Text] [Related]
2. Tumor budding in breast carcinoma: A systematic review and meta-analysis.
Buch A; Khan U; Rathod H; Jain K; Dwivedi A; Rajesh A
J Cancer Res Ther; 2023 Oct; 19(7):1697-1713. PubMed ID: 38376268
[TBL] [Abstract] [Full Text] [Related]
3. Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patients.
Saldajeno DP; Kawaoka S; Masuda N; Tanaka S; Bando H; Nishimura T; Kadoya T; Yamanaka T; Imoto S; Velaga RM; Tamura N; Aruga T; Ikeda K; Fukui Y; Maeshima Y; Takada M; Suzuki E; Ueno T; Ogawa S; Haga H; Ohno S; Morita S; Kawaguchi K; Toi M
Br J Cancer; 2024 Apr; 130(6):1023-1035. PubMed ID: 38238427
[TBL] [Abstract] [Full Text] [Related]
4. A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic breast cancer.
Cescon DW; Hilton J; Morales Murilo S; Layman RM; Pluard T; Yeo B; Park IH; Provencher L; Kim SB; Im YH; Wyce A; Krishnatry AS; Hicks K; Zhang Q; Barbash O; Khaled A; Horner T; Dhar A; Oliveira M; Sparano JA
Clin Cancer Res; 2024 Jan; 30(2):334-343. PubMed ID: 37992310
[TBL] [Abstract] [Full Text] [Related]
5. clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan.
Baba T; Kusumoto M; Kato T; Kurihara Y; Sasaki S; Oikado K; Saito Y; Endo M; Fujiwara Y; Kenmotsu H; Sata M; Takano T; Kato K; Hirata K; Katagiri T; Saito H; Kuwano K
Int J Clin Oncol; 2023 Dec; 28(12):1585-1596. PubMed ID: 37787866
[TBL] [Abstract] [Full Text] [Related]
6. 17β-hydroxysteroid dehydrogenases in the progression of nonalcoholic fatty liver disease.
Wang MX; Peng ZG
Pharmacol Ther; 2023 Jun; 246():108428. PubMed ID: 37116587
[TBL] [Abstract] [Full Text] [Related]
7. Distribution, dynamic evolution, and clinical outcomes of patients with advanced breast cancer according to HER2 expression.
Shi Q; Yu J; Liu D; Ren F; Wu J; Shen K
BMC Cancer; 2023 Feb; 23(1):173. PubMed ID: 36810001
[TBL] [Abstract] [Full Text] [Related]
8. Treatment and outcome in metastatic lobular breast cancer in the prospective German research platform OPAL.
Thill M; Zahn MO; Welt A; Stickeler E; Nusch A; Fietz T; Rauh J; Wetzel N; Kruggel L; Jänicke M; Marschner N; Harbeck N; Wöckel A; Decker T;
Breast Cancer Res Treat; 2023 Apr; 198(3):545-553. PubMed ID: 36807725
[TBL] [Abstract] [Full Text] [Related]
9. High PD-L2 Predicts Early Recurrence of ER-Positive breast cancer.
Chervoneva I; Peck AR; Sun Y; Yi M; Udhane SS; Langenheim JF; Girondo MA; Jorns JM; Chaudhary LN; Kamaraju S; Bergom C; Flister MJ; Hooke JA; Kovatich AJ; Shriver CD; Hu H; Palazzo JP; Bibbo M; Hyslop T; Nevalainen MT; Pestell RG; Fuchs SY; Mitchell EP; Rui H
JCO Precis Oncol; 2023 Jan; 7():e2100498. PubMed ID: 36652667
[TBL] [Abstract] [Full Text] [Related]
10. Muscle mass loss in breast cancer patients of reproductive age (≤ 45 years) undergoing neoadjuvant chemotherapy.
Rossi F; Lambertini M; Brunetti N; De Giorgis S; Razeti MG; Calabrese M; Tagliafico AS
Radiol Med; 2023 Jan; 128(1):49-57. PubMed ID: 36536266
[TBL] [Abstract] [Full Text] [Related]
11. Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density.
Somasundaram V; Ridnour LA; Cheng RY; Walke AJ; Kedei N; Bhattacharyya DD; Wink AL; Edmondson EF; Butcher D; Warner AC; Dorsey TH; Scheiblin DA; Heinz W; Bryant RJ; Kinders RJ; Lipkowitz S; Wong ST; Pore M; Hewitt SM; McVicar DW; Anderson SK; Chang J; Glynn SA; Ambs S; Lockett SJ; Wink DA
Redox Biol; 2022 Dec; 58():102529. PubMed ID: 36375380
[TBL] [Abstract] [Full Text] [Related]
12. outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysis.
Bianco N; Milano M; Pagan E; Oriecuia C; Bagnardi V; Rocco EG; Santomauro GI; Peruzzotti G; Colleoni M; Viale G
Breast Cancer Res Treat; 2022 Jan; 191(1):137-145. PubMed ID: 34609640
[TBL] [Abstract] [Full Text] [Related]
13. Impact of prior cancer on the overall survival of patients with nasopharyngeal carcinoma.
Wang X; Wang Z; Chen Y; Lin Q; Chen H; Lin Y; Lu L; Zheng P; Chen X
Am J Otolaryngol; 2022; 43(1):103235. PubMed ID: 34563802
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathological features of mammary Paget’s disease: a single-center experience in Turkey.
Kar H; Altındağ SD; Etit D; Yiğit S; Acar N; Tekindal MA; Gür Ö; Küçükzeybek B; Akgül Ö; Atahan K
Turk J Med Sci; 2021 Dec; 51(6):2994-3000. PubMed ID: 34493033
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathologic Characteristics and clinical outcome of Localized Liposarcoma: A Single-Center Experience over 25 Years and Evaluation of PD-L1 Expression.
Chae H; Kim JE; Kim W; Lee JS; Song SY; Lee MH; Chung HW; Cho KJ; Song JS; Ahn JH
Cancer Res Treat; 2022 Apr; 54(2):579-589. PubMed ID: 34237209
[TBL] [Abstract] [Full Text] [Related]
16. Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. clinical outcome and actionable molecular alterations.
Conforti F; Pala L; Pagan E; Rocco EG; Bagnardi V; Montagna E; Peruzzotti G; De Pas T; Fumagalli C; Pileggi S; Pesenti C; Marchini S; Corso G; Marchio' C; Sapino A; Graffeo R; Collet L; Aftimos P; Sotiriou C; Piccart M; Gelber RD; Viale G; Colleoni M; Goldhirsch A
Breast; 2021 Oct; 59():94-101. PubMed ID: 34217971
[TBL] [Abstract] [Full Text] [Related]
17. An Optimal Timing for Removing a Drain After breast Surgery: A Systematic Review and Meta-Analysis.
Shima H; Kutomi G; Sato K; Kuga Y; Wada A; Satomi F; Uno S; Nisikawa N; Kameshima H; Ohmura T; Mizuguchi T; Takemasa I
J Surg Res; 2021 Nov; 267():267-273. PubMed ID: 34171562
[TBL] [Abstract] [Full Text] [Related]
18. Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR
Dandachi N; Posch F; Graf R; Suppan C; Klocker EV; Müller HD; Lindenmann J; Terbuch A; Heitzer E; Balic M
Mol Oncol; 2021 Sep; 15(9):2390-2400. PubMed ID: 33264486
[TBL] [Abstract] [Full Text] [Related]
19. Everolimus-Related Pneumonitis in Patients with Metastatic breast cancer: Incidence, Radiographic Patterns, and Relevance to clinical outcome.
Gong C; Xiao Q; Li Y; Gu Y; Zhang J; Wang L; Cao J; Tao Z; Zhao Y; Xie Y; Hu X; Wang B
Oncologist; 2021 Apr; 26(4):e580-e587. PubMed ID: 33191524
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathological Features and outcomes in Individuals with breast cancer and ATM, CHEK2, or PALB2 Mutations.
Bergstrom C; Pence C; Berg J; Partain N; Sadeghi N; Mauer C; Pirzadeh-Miller S; Gao A; Li H; Unni N; Syed S
Ann Surg Oncol; 2021 Jun; 28(6):3383-3393. PubMed ID: 32996020
[TBL] [Abstract] [Full Text] [Related]
[Next]
